MERCALIS AND TRIANGLE INSIGHTS GROUP ANNOUNCE SENIOR LEADERSHIP APPOINTMENTS
Nicoletti is a life sciences consultant with over 20 years of experience advising biotech and pharmaceutical clients on portfolio and commercialization strategy. Her focus has involved new product planning, portfolio management, and brand and launch strategy. She is adept at building bridges across functions and telling compelling stories to support key strategic decisions. Her strong operational experience in developing consulting teams, tools, and operations has led to rapid growth of the consulting firms she has led in the past. Nicoletti earned a BS in Chemistry from the College of William and Mary and a PhD in Biochemistry from the University of Michigan.
Turner is a seasoned leader and client strategic partner with over 25 years of commercial strategy consulting experience in life sciences. He has served as an advisor to emerging and established biopharmaceutical company commercial leaders in new product planning/go-to-market strategy, commercial and competitive strategy, and portfolio strategy. Throughout his career, he has supported the commercialization of over 75 global launch products across most therapeutic areas and has helped over 20 emerging pharma companies prepare for their first US launches. As part of his launch and commercialization work, he has also worked extensively with companies on their patient and physician services programs. Turner holds a BS in Operations Research and Engineering from Cornell University's College of Engineering and an MBA from the University of Michigan's Ross School of Business.
"The addition of Aileen and Michael further strengthens the Triangle and Mercalis leadership teams," said
To learn more about Triangle Insights Group, please visit https://triangleinsightsgroup.com/.
About Triangle Insights Group
Triangle Insights Group by Mercalis is a premier strategy consulting firm providing guidance on critical business issues to life science industry leaders. The firm's approach combines deep industry knowledge with strong analytical rigor to drive strategic decision-making across client domains. Triangle's expertise encompasses key therapeutic areas (oncology, CNS, cell, and gene therapy) and relevant industry disciplines (pricing and market access, new product planning, and commercial strategy). For more information, visit www.triangleinsightsgroup.com.
About Mercalis
Mercalis is an integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company partners closely with its clients to deliver an end-to-end spectrum of commercial capabilities that work together seamlessly and flexibly. Backed by proven industry expertise and results-driven technology, Mercalis provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Above all, Mercalis helps navigate the complex life sciences marketplace to accelerate value and enhance patient lives. Founded in 2000, Mercalis provides commercialization solutions to more than 500 life sciences customers and has provided access and affordability support to millions of patients. The company is headquartered in
Contact:
VP, Marketing & Communications
Mercalis
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/mercalis-and-triangle-insights-group-announce-senior-leadership-appointments-302214506.html
SOURCE Mercalis
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADA acquires Algonomy, strengthening its intelligent growth platform for a fully agentic experience
- Actimed Therapeutics Strengthens Board with Appointment of Dr. Anders Ullman
- Relation unveils MORGAN, the next-generation model of cellular biology
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share